Preimplantation Genetic Testing Market
Preimplantation Genetic Testing Market Forecasts to 2032 – Global Analysis By Product (Reagents & Consumables, Instruments and Software), Procedure, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Preimplantation Genetic Testing Market is accounted for $883.1 million in 2025 and is expected to reach $2103.3 million by 2032 growing at a CAGR of 13.2% during the forecast period. Preimplantation genetic testing is a laboratory procedure performed on embryos created via in vitro fertilization (IVF) to identify genetic or chromosomal abnormalities before pregnancy. It involves analyzing one or more cells from the embryo to screen for inherited diseases, chromosomal normality, or other genetic conditions. This testing helps select healthy embryos for implantation, reducing the risk of genetic disorders in the offspring.
According to the U.S. Department of Health and Human Services, infertility affects millions of Americans at some point in their lives. IVF is a crucial fertility treatment, accounting for over 99% of ART procedures.
Market Dynamics:
Driver:
Increasing incidence of genetic disorders and infertility
The rising global prevalence of genetic disorders and infertility is a primary driver for the preimplantation genetic testing market. Couples opting for assisted reproductive technologies increasingly seek genetic screening to reduce the risk of inherited conditions in embryos. Advancements in diagnostic accuracy and awareness of chromosomal abnormalities have further spurred demand. With maternal age on the rise and infertility rates escalating, particularly in urban populations, PGT is emerging as a proactive solution to ensure healthy pregnancies.
Restraint:
High cost and limited reimbursement policies
Despite its clinical benefits, the high cost of preimplantation genetic testing remains a significant barrier, especially in developing economies. Limited insurance coverage and restrictive reimbursement policies discourage widespread adoption. Many patients are burdened with out-of-pocket expenses, particularly when PGT is bundled with in-vitro fertilization. Moreover, variability in regulatory frameworks across regions further constrains access. These financial and policy constraints hinder market penetration, particularly among middle-income demographics and public healthcare systems.
Opportunity:
Growing adoption of IVF and assisted reproductive technologies
Widespread adoption of in-vitro fertilization (IVF) and other assisted reproductive technologies (ART) presents a strong growth opportunity for the PGT market. As success rates of IVF improve, clinics increasingly integrate genetic testing to enhance implantation outcomes and reduce miscarriages. Rising acceptance of ART among same-sex couples, single parents, and those with recurrent pregnancy loss has broadened the patient base. The integration of AI and next-generation sequencing (NGS) further enhances PGT accuracy, attracting newer demographics and boosting clinical success.
Threat:
Lack of awareness in certain populations
Inadequate awareness regarding preimplantation genetic testing, particularly in rural and underdeveloped regions, poses a critical threat to market expansion. Misconceptions, socio-cultural taboos, and limited genetic literacy reduce adoption rates despite increasing infertility cases. Additionally, lack of education among patients and healthcare providers about the benefits and eligibility criteria of PGT hinders early consultation. This awareness gap continues to delay timely intervention, particularly among high-risk carriers of genetic diseases, curbing the market’s full potential.
Covid-19 Impact:
The COVID-19 pandemic disrupted fertility services globally, leading to postponed IVF cycles and a temporary decline in PGT procedures. Clinics faced staff shortages, mobility restrictions, and supply chain interruptions for reagents and test kits. However, post-pandemic recovery has been marked by a rebound in fertility treatments and increased emphasis on genetic health. Telemedicine, digitized consultations, and remote genetic counseling have helped restore patient engagement, supporting renewed growth in PGT services amid strengthened healthcare digitization.
The reagents & consumables segment is expected to be the largest during the forecast period
The reagents & consumables segment is expected to account for the largest market share during the forecast period, due to its recurring demand across every testing cycle. Laboratories rely on high-quality reagents, probes, and kits for accurate embryo analysis, driving consistent consumption. Continuous advancements in molecular diagnostic tools and NGS-based testing have also increased demand for specialized reagents. Additionally, the growing volume of IVF procedures globally necessitates regular procurement of consumables, making this segment a critical revenue driver for diagnostic suppliers.
The preimplantation genetic screening segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the preimplantation genetic screening segment is predicted to witness the highest growth rate, impelled by the growing desire to improve IVF success rates and prevent chromosomal abnormalities. PGS aids in identifying aneuploidy and structural rearrangements, enabling the selection of genetically viable embryos. As maternal age rises, especially in developed nations, the relevance of PGS continues to grow. Additionally, the integration of NGS and automated analytics is enhancing efficiency, accuracy, and accessibility of screening protocols.
Region with largest share:
During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by expanding fertility tourism, rising infertility rates, and increased ART adoption. Countries like India, China, and Japan are witnessing a surge in advanced reproductive services, backed by improving healthcare infrastructure and supportive policies. In addition, growing medical tourism and competitive treatment costs attract international patients. The region's large reproductive-age population and rising awareness around genetic health contribute to its dominant market position.
Region with highest CAGR:
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR attributed to advanced healthcare infrastructure, high adoption of ART, and favorable reimbursement scenarios in select states. Strong demand for personalized reproductive solutions and early screening among older parents bolsters PGT uptake. Furthermore, the presence of leading genomic testing firms, regulatory clarity, and ongoing clinical innovations in embryo diagnostics support rapid market expansion. Patient awareness and fertility education initiatives also enhance regional growth momentum.
Key players in the market
Some of the key players in Preimplantation Genetic Testing Market include Illumina, Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., CooperSurgical, Abbott Laboratories, Natera, Rubicon Genomics, Oxford Gene Technology, Yikon Genomics, Good Start Genetics, Invicta Genetics, Progenesis, Igenomix, Bioarray S.L., Quest Diagnostics, Fulgent Genetics, Inc., Labcorp, and Genea Limited.
Key Developments:
In February 2025, Thermo Fisher Scientific expanded its PGT capabilities with an integrated NGS workflow allowing a single sample to be assessed for both PGT-A (aneuploidy) and PGT-M (monogenic disorders) using Ion Torrent technology—offering comprehensive results with rapid turnaround and accessible analysis tools.
In January 2025, Illumina launched major upgrades to its NovaSeq X Series, including a new single-flow-cell system, advanced software, and improved reagent kits, further strengthening its leadership in genomic sequencing, a key technology for PGT.
Products Covered:
• Reagents & Consumables
• Instruments
• Software
Procedures Covered:
• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis
Technologies Covered:
• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescent In-Situ Hybridization (FISH)
• Other Technologies
Applications Covered:
• Chromosomal Abnormalities
• X-linked Diseases
• Embryo Testing
• Aneuploidy Screening
• HLA Typing
• Other Applications
End Users Covered:
• Fertility Centers
• Hospitals
• Diagnostic Centers
• Research Centers & Academic Labs
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Preimplantation Genetic Testing Market, By Product
5.1 Introduction
5.2 Reagents & Consumables
5.3 Instruments
5.4 Software
6 Global Preimplantation Genetic Testing Market, By Procedure
6.1 Introduction
6.2 Preimplantation Genetic Screening
6.3 Preimplantation Genetic Diagnosis
7 Global Preimplantation Genetic Testing Market, By Technology
7.1 Introduction
7.2 Next Generation Sequencing (NGS)
7.3 Polymerase Chain Reaction (PCR)
7.4 Fluorescent In-Situ Hybridization (FISH)
7.5 Other Technologies
8 Global Preimplantation Genetic Testing Market, By Application
8.1 Introduction
8.2 Chromosomal Abnormalities
8.3 X-linked Diseases
8.4 Embryo Testing
8.5 Aneuploidy Screening
8.6 HLA Typing
8.7 Other Applications
9 Global Preimplantation Genetic Testing Market, By End User
9.1 Introduction
9.2 Fertility Centers
9.3 Hospitals
9.4 Diagnostic Centers
9.5 Research Centers & Academic Labs
10 Global Preimplantation Genetic Testing Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Illumina, Inc.
12.2 Thermo Fisher Scientific, Inc.
12.3 Agilent Technologies, Inc.
12.4 PerkinElmer, Inc.
12.5 CooperSurgical
12.6 Abbott Laboratories
12.7 Natera
12.8 Rubicon Genomics
12.9 Oxford Gene Technology
12.10 Yikon Genomics
12.11 Good Start Genetics
12.12 Invicta Genetics
12.13 Progenesis
12.14 Igenomix
12.15 Bioarray S.L.
12.16 Quest Diagnostics
12.17 Fulgent Genetics, Inc.
12.18 Labcorp
12.19 Genea Limited
List of Tables
1 Global Preimplantation Genetic Testing Market Outlook, By Region (2024-2032) ($MN)
2 Global Preimplantation Genetic Testing Market Outlook, By Product (2024-2032) ($MN)
3 Global Preimplantation Genetic Testing Market Outlook, By Reagents & Consumables (2024-2032) ($MN)
4 Global Preimplantation Genetic Testing Market Outlook, By Instruments (2024-2032) ($MN)
5 Global Preimplantation Genetic Testing Market Outlook, By Software (2024-2032) ($MN)
6 Global Preimplantation Genetic Testing Market Outlook, By Procedure (2024-2032) ($MN)
7 Global Preimplantation Genetic Testing Market Outlook, By Preimplantation Genetic Screening (2024-2032) ($MN)
8 Global Preimplantation Genetic Testing Market Outlook, By Preimplantation Genetic Diagnosis (2024-2032) ($MN)
9 Global Preimplantation Genetic Testing Market Outlook, By Technology (2024-2032) ($MN)
10 Global Preimplantation Genetic Testing Market Outlook, By Next Generation Sequencing (NGS) (2024-2032) ($MN)
11 Global Preimplantation Genetic Testing Market Outlook, By Polymerase Chain Reaction (PCR) (2024-2032) ($MN)
12 Global Preimplantation Genetic Testing Market Outlook, By Fluorescent In-Situ Hybridization (FISH) (2024-2032) ($MN)
13 Global Preimplantation Genetic Testing Market Outlook, By Other Technologies (2024-2032) ($MN)
14 Global Preimplantation Genetic Testing Market Outlook, By Application (2024-2032) ($MN)
15 Global Preimplantation Genetic Testing Market Outlook, By Chromosomal Abnormalities (2024-2032) ($MN)
16 Global Preimplantation Genetic Testing Market Outlook, By X-linked Diseases (2024-2032) ($MN)
17 Global Preimplantation Genetic Testing Market Outlook, By Embryo Testing (2024-2032) ($MN)
18 Global Preimplantation Genetic Testing Market Outlook, By Aneuploidy Screening (2024-2032) ($MN)
19 Global Preimplantation Genetic Testing Market Outlook, By HLA Typing (2024-2032) ($MN)
20 Global Preimplantation Genetic Testing Market Outlook, By Other Applications (2024-2032) ($MN)
21 Global Preimplantation Genetic Testing Market Outlook, By End User (2024-2032) ($MN)
22 Global Preimplantation Genetic Testing Market Outlook, By Fertility Centers (2024-2032) ($MN)
23 Global Preimplantation Genetic Testing Market Outlook, By Hospitals (2024-2032) ($MN)
24 Global Preimplantation Genetic Testing Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
25 Global Preimplantation Genetic Testing Market Outlook, By Research Centers & Academic Labs (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
